Search

everythinglearnresearchcommunity

for

Search:↓

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

The document explains various skin conditions and their treatments.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Hair color production in mice is closely linked to the hair growth phase and may also influence hair growth itself.

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Some breast cancer chemotherapy can cause permanent hair loss.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Cetuximab can cause eyelash growth, which is rare but manageable.

Where melanoma is on the body affects survival chances; melanomas on the back of the head are worse, while those on thighs and arms are less severe, and more sun exposure might improve survival.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Iron deficiency might contribute to hair loss in women.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.